Ortec International said Tuesday (20th June) the European patent office has granted the firm a patent on its Fibrin Microbead technology for isolating certain types of adult stem cells. The technology has previously been granted five U.S. patents.

The Fibrin technology is a proprietary matrix for isolating, expanding and differentiating Mesenchymal-type adult stem cells, a process that could be useful for using the cells to treat patients.

Link


  • Stem-Cell Patents to be Reviewed by the Federal Government
  • Korean Govt. Offers Support for Stem Cell Research by Prof. Hwang Woo-suk
  • Reliance Life Sciences Files US Patent for Improved Techniques to Harvest Stem Cells from Embryonic and Placental Cord Blood Cells
  • Artecel & University of Pittsburgh Wins Legal Victory Over Adipose-Derived Stem Cell Patent
  • Sickle Cell Mutation Provides Faster & More Efficient Adult Stem Cell Reprogramming To Embryonic Like Stem Cells
  • Cord Blood may become Key Source of Stem Cells
  • BioArchive - Automated Blood Freezer for Cord Blood Stem Cell Storage
  • Stem Cell Research Gets $1 Million Seed Money
  • Cord Blood Stem Cells Safely and Effectively Reproduced in Japan
  • Stem Cell Cures Pelvic Floor Prolapse In Women Through Tissue Engineering